BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 14965711)

  • 1. C-myc oncoprotein expression and gene amplification in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
    Selim AG; El-Ayat G; Naase M; Wells CA
    Breast; 2002 Dec; 11(6):466-72. PubMed ID: 14965711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
    Selim AG; El-Ayat G; Wells CA
    Virchows Arch; 2002 Nov; 441(5):449-55. PubMed ID: 12447674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-erbB2 oncoprotein expression, gene amplification, and chromosome 17 aneusomy in apocrine adenosis of the breast.
    Selim AG; El-Ayat G; Wells CA
    J Pathol; 2000 Jun; 191(2):138-42. PubMed ID: 10861572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
    Elayat G; Selim AG; Wells CA
    Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenes, granules and breast cancer: what has c-myc to do with apocrine changes?
    Schmitt FC; Reis-Filho JS
    Breast; 2002 Dec; 11(6):463-5. PubMed ID: 14965710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D-1 protein over-expression is not associated with gene amplification in benign and atypical apocrine lesions of the breast.
    Elayat G; Selim AG; Gorman P; Tomlinson I; Wells CA
    Pathol Res Pract; 2011 Feb; 207(2):75-8. PubMed ID: 21159451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the c-myc oncoprotein in human metaplastic epithelial cells of fibrocystic disease.
    Papamichalis G; Francia K; Karachaliou FE; Anastasiades OT; Spandidos DA
    Anticancer Res; 1988; 8(6):1217-22. PubMed ID: 3064712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization.
    Shimada M; Imura J; Kozaki T; Fujimori T; Asakawa S; Shimizu N; Kawaguchi R
    Oncol Rep; 2005 Apr; 13(4):633-41. PubMed ID: 15756435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas.
    Washington C; Dalbègue F; Abreo F; Taubenberger JK; Lichy JH
    Am J Pathol; 2000 Jul; 157(1):323-9. PubMed ID: 10880402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle alterations and their relationship to proliferation in apocrine adenosis of the breast.
    Elayat G; Selim AG; Wells CA
    Histopathology; 2009 Feb; 54(3):348-54. PubMed ID: 19236511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c -MYC amplification and expression in astrocytic tumors.
    Faria MH; Khayat AS; Burbano RR; Rabenhorst SH
    Acta Neuropathol; 2008 Jul; 116(1):87-95. PubMed ID: 18369647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of HER2 and C-MYC oncogene amplifications in breast cancer in atomic bomb survivors: associations with radiation exposure and histologic grade.
    Miura S; Nakashima M; Ito M; Kondo H; Meirmanov S; Hayashi T; Soda M; Matsuo T; Sekine I
    Cancer; 2008 May; 112(10):2143-51. PubMed ID: 18348306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
    Salido M; Tusquets I; Corominas JM; Suarez M; Espinet B; Corzo C; Bellet M; Fabregat X; Serrano S; Solé F
    Breast Cancer Res; 2005; 7(2):R267-73. PubMed ID: 15743507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MYC oncogene in breast cancer progression: from benign epithelium to invasive carcinoma.
    Corzo C; Corominas JM; Tusquets I; Salido M; Bellet M; Fabregat X; Serrano S; Solé F
    Cancer Genet Cytogenet; 2006 Mar; 165(2):151-6. PubMed ID: 16527609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-needle aspiration cytology of apocrine adenosis of the breast: report on three cases.
    Watanabe K; Nomura M; Hashimoto Y; Hanzawa M; Hoshi T
    Diagn Cytopathol; 2007 May; 35(5):296-9. PubMed ID: 17427223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential HER-2/neu overexpression and/or amplification in aggressive histological subtypes of invasive breast cancer.
    Varga Z; Zhao J; Ohlschlegel C; Odermatt B; Heitz PU
    Histopathology; 2004 Apr; 44(4):332-8. PubMed ID: 15049898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC amplification and TERT expression in breast tumor progression.
    Bodvarsdóttir SK; Steinarsdóttir M; Hilmarsdóttir H; Jónasson JG; Eyfjörd JE
    Cancer Genet Cytogenet; 2007 Jul; 176(2):93-9. PubMed ID: 17656250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative implication of C-MYC as an amplification target in esophageal cancer.
    Huang XP; Rong TH; Wang JY; Tang YQ; Li BJ; Xu DR; Zhao MQ; Zhang LJ; Fang Y; Su XD; Liang QW
    Cancer Genet Cytogenet; 2006 Feb; 165(1):20-4. PubMed ID: 16490593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-myc amplifications in primary breast carcinomas and their local recurrences.
    Aulmann S; Adler N; Rom J; Helmchen B; Schirmacher P; Sinn HP
    J Clin Pathol; 2006 Apr; 59(4):424-8. PubMed ID: 16497871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.